pan-KRAS degrader / Dr. Reddy’s - LARVOL DELTA

Discovery and development of a highly co-operative and potent pan-KRAS degrader (AACR 2025) - "Notably, the development candidate compound has demonstrated excellent PK and tolerability in rodent and non-rodent tox species. IND enabling studies are ongoing to support clinical development."

Colorectal Cancer • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor • HRAS • KRAS • NRAS